Corcept Therapeutics
CORT
NASDAQ
IPO2004
about CORT
Corcept Therapeutics develops innovative treatments for serious metabolic and endocrine diseases, including its flagship product for conditions such as Cushing's syndrome.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $38.89 | $39.00 | $32.99 | $7.4B | 20.31M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.19 | 33.64 | 19.93 | 4.92% | 9.47% | 0% |